Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer leads Big Pharma's emerging markets growth as GlaxoSmithKline, Eli Lilly lag
Fierce Pharma
Wed, 09/20/17 - 11:08 pm
Tags:
Pfizer, GSK, Eli Lilly, emerging markets
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wed, 09/20/17 - 11:03 am
Tags:
Pfizer, JNJ, Janssen, Remicade, biosimilars, Inflectra
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
Tags:
drug pricing, reimbursement, Remicade, biosimilars, Janssen, Inflectra, Pfizer, Renflexis, Merck
New PhIII data in hand, Pfizer, Astellas hustle ahead in bid to expand US market for Xtandi
Endpoints
Thu, 09/14/17 - 10:27 am
Tags:
Pfizer, Astellas, clinical trials, Xtandi, prostate cancer
Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates
Fierce Pharma
Tue, 09/12/17 - 09:47 pm
Tags:
Prevnar 13, vaccines, licensing, Pfizer
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
Mon, 09/11/17 - 09:06 pm
Tags:
AbbVie, Pfizer, JNJ, drug ads, television ads
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer
Motley Fool
Mon, 09/11/17 - 09:54 am
Tags:
Allergan, patents, Restasis, Pfizer
#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage
Endpoints
Mon, 09/11/17 - 09:17 am
Tags:
ESMO, Eli Lilly, Pfizer, Novartis, abemaciclib, breast cancer
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
RAPS.org
Fri, 09/8/17 - 09:28 am
Tags:
FDA, Celltrion, biosimilars, Pfizer, Inflectra, Remicade
EpiPen Maker Neglected ‘Hundreds’ of Complaints About Defects
Bloomberg
Thu, 09/7/17 - 05:41 pm
Tags:
EpiPens, Mylan Labs, Pfizer, Meridian Medical Technologies
Pfizer puts hemophilia spin on ultrapopular Minecraft to educate young patients
Fierce Pharma
Wed, 09/6/17 - 08:42 pm
Tags:
Pfizer, hemophilia, patients
Allergan-Restasis Patent Battle Could Test Lawmakers' Resolve
NY Shock Exchange
Wed, 09/6/17 - 09:11 am
Tags:
Allergan, Restasis, patents, Mylan Labs, Pfizer, Teva Pharmaceutical, Shire
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
Tags:
FDA, Mylan Labs, Herceptin, biosimilars, trastuzumab, Shingrix, GSK, Pfizer, Sutent, PTC Therapeutics, Translarna, Amgen, Allergan, Avastin
FDA Approves Pfizer’s Mylotarg 7 Years After it was Pulled From the Market
RAPS.org
Fri, 09/1/17 - 04:06 pm
Tags:
Pfizer, FDA, Mylotarg, acute myeloid leukemia, AML
Bristol-Myers, Pfizer continue to build case for Eliquis
BioPharma Dive
Tue, 08/29/17 - 09:49 am
Tags:
Bristol-Myers Squibb, Pfizer, Eliquis, blood thinners
Top 25 vaccine products in 2016, based on U.S. sales
Medical Marketing and Media
Mon, 08/28/17 - 10:33 pm
Tags:
vaccines, Pfizer, Merck, Sanofi, Prevnar 13, Gardasil, Fluzone, Varivax, Menactra
Best Pharma Stocks Based on R&D Spending
Motley Fool
Mon, 08/28/17 - 09:27 am
Tags:
R&D, pharma stocks, Roche, Novartis, Pfizer, JNJ, Merck
Pfizer's hunt for new Manhattan HQ lands on snazzy Spiral skyscraper: report
Fierce Pharma
Fri, 08/25/17 - 11:38 am
Tags:
Pfizer
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
Fierce Pharma
Thu, 08/24/17 - 05:11 pm
Tags:
Novartis, Kisqali, Pfizer, Ibrance, reimbursement, breast cancer
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
Fierce Pharma
Wed, 08/23/17 - 11:21 am
Tags:
Pfizer, Eucrisa, DTC, eczema, Dupixent, Sanofi, Regeneron

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.